Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Ketamine Plus Midazolam Versus Ketamine Plus Midazolam for the Treatment of Refractory Status Epilepticus

NCT07177235 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT07177235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07177235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Ketamine Plus Midazolam Versus Ketamine Plus Midazolam for the Treatment of Refractory Status Epilepticus
Lead sponsor
Thomas Jefferson University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 30, 2025
Completion date
July 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory status epilepticus